期刊文献+

膀胱癌基底膜层粘蛋白、胶原蛋白Ⅳ与纤维连接蛋白分布表达的相关性研究 被引量:4

Relative study on the relationship among laminin、collagen type Ⅳ and fibronectin distribution and expression at basement membrane in bladder carcinoma
原文传递
导出
摘要 目的探讨膀胱癌基底膜中层粘蛋白、胶原蛋白Ⅳ与纤维连接蛋白分布表达的相关性。方法用免疫组织化学方法测定35例膀胱移行上皮癌和3例低分化鳞状上皮癌肿瘤组织基底膜层粘蛋白(LN)、胶原蛋白Ⅳ(Col Ⅳ)和纤维连接蛋白(FN)含量与分布。结果病理级别高、浸润性生长的膀胱移行上皮癌,基底膜LN、Col Ⅳ和FN一样,阳性染色少,分布不连续;反之,病理级别低、非浸润性生长的肿瘤,基底膜LN、Col Ⅳ也和FN一致,阳性染色多,分布呈连续性。低分化鳞状上皮癌基底膜LN、Col Ⅳ和FN分布含量同样呈正相关。结论膀胱肿瘤基底膜LN、Col Ⅳ和FN分布含量高度一致,它们的丧失可作为肿瘤恶性度高的指标之一。 Objective In order to explore the relationship among laminin (LN), collagen type Ⅳ (Col Ⅳ) and fibronectin (FN) express on at basement membrane (BM) in patients with bladder carcinoma and their clinical implications. Methods Distribution of LN, Col Ⅳ and FN at BM were studied by immunoperoxi- dase technique in 35 patients with bladder transitional cell carcinoma and 3 with squamous cell carcino- ma. Results The poorer the tumour differentiation or the deeper the tumour invasion, the more the loss of LN, Col Ⅳ and FN at BM in patients with bladder transitional cell carcinoma. The expressions of LN, Col Ⅳ and FN at BM in patients with squamous cell carcinoma were reduced. Conclusions The losing de- grees of LN and Col Ⅳ corresponded to the losing degree of FN. The absence of LN, Col Ⅳ as well as FN at BM can be used to predict the malignant tendency in patients with bladder neoplasm.
出处 《中华实验外科杂志》 CSCD 北大核心 1998年第1期46-47,共2页 Chinese Journal of Experimental Surgery
关键词 膀胱肿瘤 层粘蛋白 胶原蛋白Ⅳ 纤维连接蛋白 Bladder neoplasm Laminin Collagen type Ⅳ Fibronectin
  • 相关文献

参考文献1

  • 1尹玉新,中华病理学杂志,1989年,18卷,125页

同被引文献40

  • 1Vamer JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Bi- ol, 1996, 8(5) : 724 -730.
  • 2Schapers RF, Pauwels RP, Havenith MG F, et al. Prognostic sig- nificance of type IV collagen and laminin urothelial carcinomas of the bladder. Cancer 2583 - 2588. 1990, 66 (12).
  • 3Szarvas T, Laszlo V, Vom DF, et al. Serum endostatin levels cor- relate with enhanced extracellular matrix degradation and poor pa-tients" prognosis in bladder cancer. Int J Cancer, 201 1, Aug 3. doi .. 10. 1002/ijc. 26343.
  • 4Nusgens BV. Hyalumnic acid and extracellular matrix: a primitive molecule. Ann Dermatol Venereol, 2010, 137 Suppl 1 : S3 - 8.
  • 5Golshani R, Lopez L, Estrella V F, et al. Hyaluronic acid syn- thase- 1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res, 2008, 68 (2) : 483 -491.
  • 6Kramer MW, Escudero DO, Lokeshwar SD, et al. Association of hyaluronic acid family members ( HASI, HAS2, and HYAL - 1 ) with bladder cancer diagnosis and prognosis. Cancer, 2011, 117 (6) : 1197 -1209.
  • 7Iozzo RV. Heparan sulfate proteoglycans : intricate molecules with intriguing functions. J Clin Invest, 2001, 108(2) : 165 - 167.
  • 8Naggi A, Casu B, Perez M, et al. Modulation of the heparanase - inhibiting activity of heparin through selective desulfation, gra- ded N - acetylation, and glycol splitting. J Biol Chem, 2005, 280( 13 ) : 12103 - 12113.
  • 9Li JP. Heparin, heparan sulfate and heparanase in cancer: reme- dy for metastasis. Anticancer Agents Med Chem, 2008, 8 ( 1 ) : 64 -76.
  • 10Kim S, Bell K, Mousa SA F, et al. Regulation of angiogenesis in vivo by ligation of integrin alpha5betal with the central cell - binding domain of fibronectin. Am J Pathol, 2000, 156 ( 4 ) : 1345 - 1362.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部